Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Non-cash Items (2016 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Non-cash Items for 8 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 2.99% year-over-year to $7.1 million, compared with a TTM value of $7.1 million through Dec 2025, down 2.99%, and an annual FY2025 reading of $7.1 million, down 2.99% over the prior year.
  • Non-cash Items was $7.1 million for Q4 2025 at Catalyst Pharmaceuticals, down from $7.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $7.4 million in Q4 2024 and bottomed at $7.1 million in Q4 2025.